LifeChain Financial is a U.S.-based alternative asset acquisition platform. We build institutionally diversified portfolios of permanent life insurance policies — applying actuarial discipline to a market that rewards patience, precision, and information advantage.
The strategy behind LifeChain traces its origins to the 1980s — when financial professionals first began exploring the secondary life insurance market as a solution for policyholders who had been declined by traditional insurers. The core insight was straightforward: policies being surrendered or lapsed at a fraction of their worth had real, quantifiable value that the market was systematically failing to capture.
That insight grew into an industry. And over the decades, the life settlement market matured from a niche concept into one of the largest and fastest-growing alternative asset categories in the world.
LifeChain was built to operate at the institutional level of that market — applying the disciplines of actuarial science, portfolio construction, and rigorous underwriting to an asset class that continues to be underserved by sophisticated capital.
We do not compete for the same policies as the traditional secondary market. We identified a distinct segment — earlier-stage, lower-competition policies — where our actuarial advantage and acquisition economics are most durable. That is the edge LifeChain is built on.
Life settlement concept emerges — policyholders find a secondary market for unwanted coverage
Institutional adoption begins. Actuarial modeling becomes standard. State regulation expands.
Market grows into a multi-billion dollar asset class. Family offices and pension funds enter.
Baby Boomer demographic wave creates unprecedented supply. Market expands to ~$100B estimated annual opportunity.
Institutional-grade acquisition platform targeting the market's most underserved and advantaged segment.
LifeChain's leadership brings together deep expertise across life insurance, institutional finance, estate planning, accounting, and insurance law.
MDRT-level credentials and direct carrier relationships across the U.S. market. Deep practitioner understanding of the secondary market's acquisition economics.
Experience structuring and managing alternative asset portfolios for qualified capital partners. Background in accounting, reporting, and globally operating companies.
Third-party actuarial underwriting on every acquisition. Legal and compliance framework supported by insurance-specialized counsel experienced in life settlement regulation and private placement structuring.
Qualified investors and institutional partners may contact the team directly at investor@lifechainfinancial.com
We do not speculate on mortality. We model it — using independent third-party actuarial review on every acquisition, annual medical file reviews throughout the holding period, and conservative assumptions at the portfolio level. Our edge is information depth, not risk appetite.
LifeChain's return profile is not a function of equity markets, interest rates, GDP growth, or credit spreads. It is a function of actuarial modeling and the claims-paying obligations of investment-grade insurance carriers. That structural independence is not a feature — it is the core of what we offer.
Every acquisition portfolio is built to institutional standards: diversified across carriers, ages, policy sizes, and geographies. Concentration limits are applied at every level. The result is a portfolio where individual outcomes matter less than aggregate actuarial performance — which is exactly how it should be designed.
Request the LifeChain investor overview to explore the full acquisition strategy, return modeling, and private placement structure.
Request the Investor Overview